Cargando…
Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Libbey Eurotext
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354837/ https://www.ncbi.nlm.nih.gov/pubmed/34309530 http://dx.doi.org/10.1684/ejd.2021.4043 |
| _version_ | 1783736660359380992 |
|---|---|
| author | Cozzani, Emanuele Gasparini, Giulia Sticchi, Laura Russo, Roberto Icardi, Giancarlo Parodi, Aurora |
| author_facet | Cozzani, Emanuele Gasparini, Giulia Sticchi, Laura Russo, Roberto Icardi, Giancarlo Parodi, Aurora |
| author_sort | Cozzani, Emanuele |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8354837 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Libbey Eurotext |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83548372021-08-11 Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases Cozzani, Emanuele Gasparini, Giulia Sticchi, Laura Russo, Roberto Icardi, Giancarlo Parodi, Aurora Eur J Dermatol Correspondence John Libbey Eurotext 2021-08-11 2021 /pmc/articles/PMC8354837/ /pubmed/34309530 http://dx.doi.org/10.1684/ejd.2021.4043 Text en © JLE/Springer 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence Cozzani, Emanuele Gasparini, Giulia Sticchi, Laura Russo, Roberto Icardi, Giancarlo Parodi, Aurora Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases |
| title | Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases |
| title_full | Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases |
| title_fullStr | Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases |
| title_full_unstemmed | Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases |
| title_short | Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases |
| title_sort | considerations on sars-cov-2 vaccines in patients with autoimmune blistering diseases |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354837/ https://www.ncbi.nlm.nih.gov/pubmed/34309530 http://dx.doi.org/10.1684/ejd.2021.4043 |
| work_keys_str_mv | AT cozzaniemanuele considerationsonsarscov2vaccinesinpatientswithautoimmuneblisteringdiseases AT gasparinigiulia considerationsonsarscov2vaccinesinpatientswithautoimmuneblisteringdiseases AT sticchilaura considerationsonsarscov2vaccinesinpatientswithautoimmuneblisteringdiseases AT russoroberto considerationsonsarscov2vaccinesinpatientswithautoimmuneblisteringdiseases AT icardigiancarlo considerationsonsarscov2vaccinesinpatientswithautoimmuneblisteringdiseases AT parodiaurora considerationsonsarscov2vaccinesinpatientswithautoimmuneblisteringdiseases |